| 发明名称 |
METHODE ZUR OPTIMIERUNG DER VERWENDUNG VON 6-MERCAPTOPURIN IN DER BEHANDLUNG VON IMMUN-VERMITTELTEN GASTROINTESTINALEN STÖRUNGEN |
| 摘要 |
The present invention provides a method of optimizing therapeutic efficacy and reducing toxicity associated with 6-mercaptopurine drug treatment of an immune-mediated gastrointestinal disorder such as inflammatory bowel disease. The method of the invention includes the step of determining the level of one or more 6-mercaptopurine metabolites in the patient having an immune-mediated gastrointestinal disorder. |
| 申请公布号 |
DE69928950(D1) |
申请公布日期 |
2006.01.19 |
| 申请号 |
DE1999628950 |
申请日期 |
1999.09.24 |
| 申请人 |
HOPITAL SAINTE-JUSTINE, MONTREAL |
发明人 |
SEIDMAN, ERNEST G.;THEORET, YVES |
| 分类号 |
A61K31/52;A61K31/522;A61P1/04;G01N33/00 |
主分类号 |
A61K31/52 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
